Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
PRA International, U.S. Oncology enter strategic alliance
February 27th, 2007
PRA International (PRAI) and U.S. Oncology Research have entered into an agreement designed to accelerate the clinical development of new cancer treatments in the United States. This new agreement will align the operational processes between the two organizations and reduce the potential for redundancies or conflicts that can hamper the timely implementation of a trial. For example, utilizing U.S. Oncology's historical working relationships with each of the research sites, a more detailed feasibility can be performed to accurately forecast the eligible population and timeframes required for the trial. Also, by eliminating the duplication of reviewing regulatory...
Source: Cancer Weekly (2007-02-27)
|
